For example, we additionally tested whether BPD participants who endorsed micropsychotic symptoms (e.g., transient, stress-related paranoid ideation or severe dissociative symptoms—one DSM-5 criterion for BPD) had differences in FAAH binding for each ROI compared with those who did not experience micropsychotic symptoms. The gene discussed is FAAH; the disease is Borderline personality disorder.